Crosspoint Capital Strategies’s Colgate-Palmolive CL Stock Holding History

Crosspoint Capital Strategies’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,386	Closed	-$96K	–	219
2015 Q4	$96K	Sell	1,386 -21,900	-94%	-$1.46M	0.03%	336
2015 Q3	$1.48M	Buy	23,286 +6,703	+40%	+$438K	1.71%	9
2015 Q2	$1.08M	Sell	16,583 -70	-0.4%	-$4.75K	0.31%	63
2015 Q1	$1.16M	Buy	16,653 +3,545	+27%	+$245K	0.56%	54
2014 Q4	$907K	Buy	13,108 +11,792	+896%	+$796K	0.32%	96
2014 Q3	$86K	Hold	1,316	–	–	0.06%	174
2014 Q2	$89K	Hold	1,316	–	–	0.03%	202
2014 Q1	$85K	Hold	1,316	–	–	0.03%	203
2013 Q4	$83K	Buy	+1,316	New	+$84.2K	0.03%	214

Other funds holding CL

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Crosspoint Capital Strategies's CL Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Colgate-Palmolive (CL) in Q1 2016, closing a stake of 1,386 shares — an estimated $96K sold.

Crosspoint Capital Strategies first reported a position in CL in Q4 2013 and held it in 9 quarters. The position peaked at $1.48M in Q3 2015. 1,263 funds tracked by Wall St. Rank hold CL as of Q1 2016.

Crosspoint Capital Strategies reported no remaining Colgate-Palmolive position as of Q1 2016 after selling out during the quarter.
Crosspoint Capital Strategies sold 1,386 Colgate-Palmolive shares in Q1 2016, an estimated $96K.
Crosspoint Capital Strategies first reported a position in Colgate-Palmolive in Q4 2013 and held it in 9 quarters.
Crosspoint Capital Strategies's Colgate-Palmolive position peaked at $1.48M in Q3 2015.
1,263 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.